The CRO industry is predicted to grow considerably over the next five years. Trials are becoming more complex, and technology is becoming increasingly interwoven with processes. The CRO of tomorrow must be tech smart, agile, and environmentally conscious to remain relevant. In this changing landscape, how does a CRO cut through the noise in 2022-30?
Adrenomed set to start pivotal trial in sepsis
Latest NewsGerman Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.
A spotlight on tomorrow’s CRO
BackgroundThe CRO industry is predicted to grow considerably over the next five years. Trials are becoming more complex, and technology is becoming increasingly interwoven with processes. The CRO of tomorrow must be tech smart, agile, and environmentally conscious to remain relevant. In this changing landscape, how does a CRO cut through the noise in 2022-30?
Mablink raises $31m in Series A financing
Latest NewsExperts showcase next-gen biotech solutions to climate crisis
Latest NewsIndustry experts have presented the latest biotech solutions for tackling climate change at the first INDUSTRIA BIOTEC conference, Europe’s new forum for the industrial biotech sector.
Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
Latest NewsPrecision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia.
Knowledge-based contract services
BackgroundTo install a newly created Chief Scientific Officer position and to hire a biotech veteran is a signal sent by Rentschler Biopharma, celebrating 150 years.
Clinical Microbiomics A/S bags €10m financing
Latest NewsDanish microbiome specialist Clinical Microbiomics A/S has completed a €10m growth financing led by – Seventure Partners.
EU starts largest study on factors affecting mental health
Latest NewsThe EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence.
Standing Ovation wins Industria Biotec’s start-up pitch
Latest NewsFrench Standing Ovation has won the start-up pitch of Industria Biotec, held for the first time in Berlin. The event presents biotechnological solutions to save the climate.
Screening Platform
ProductsSingle B cell screening is a powerful and efficient strategy for generating antigen-specific monoclonal antibodies (mAbs).